Patrick J. McEnany, Chairman and CEO of Catalyst Pharmaceuticals, Receives Prestigious 2023 Lifetime Achievement Award from BioFlorida

CORAL GABLES, Fla., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company, today announced that Patrick J. McEnany, Founder, Chairman and CEO of Catalyst, has been bestowed the 2023 Lifetime Achievement Award by BioFlorida at their Annual Meeting last Friday. This prestigious award highlights Mr. McEnany's outstanding accomplishments, unwavering commitment to rare disease patients, dedication to Cat

Related Keywords

Florida ,United States ,Canada ,Miami ,Coral Gables ,America ,David Schull Russo ,Nancyk Bryan ,Patrickj Mcenany ,Patrick Mcenany ,Exchange Commission ,Mary Coleman Catalyst Pharmaceuticals ,Catalyst Pharmaceuticals ,Humane Society Of Greater Miami ,Catalyst Or Company Nasdaq ,Watson Pharmaceuticals Inc ,Jackson Health Foundation ,National Association Of Pharmaceutical Manufacturers ,Royce Laboratories Inc ,Corporate Development For Watson ,Catalyst Pharmaceuticals Inc ,Health Canada ,Achievement Award ,Annual Meeting ,Chief Executive Officer ,Royce Laboratories ,Watson Pharmaceuticals ,Vice President ,Corporate Development ,Vice Chairman ,National Association ,Pharmaceutical Manufacturers ,Humane Society ,North America ,Duchenne Muscular ,Fast Track ,Full Prescribing ,Safety Information ,Full Prescribing Information ,Annual Report ,Investor Relations ,David Schull Russo Partners ,Bioflorida ,Lifetime Achievement Award ,Unwavering Commitment ,Chairman And Ceo ,Iopharmaceutical Company ,Mcenany ,